reviewNature Reviews Drug DiscoveryMay 16, 2014Closed access

Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework

DCDavid CookDSDearg S. BrownRARobert AlexanderRMRuth MarchPMPaul Morgan

AstraZeneca (United Kingdom) · AstraZeneca (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,342
total citations
FWCI
131.39
Percentile
100%
References
76
Citations per year

Authors

7

Topics & keywords

Topics
Keywords
  • Productivity
  • Pipeline (software)
  • Quality (philosophy)
  • Business
  • Drug development
  • Sustainable development
  • Pharmaceutical industry
  • Process management
UN Sustainable Development Goals
  • Industry, innovation and infrastructure
No related works found for this paper.